Logo image of JBTM

JBT MAREL CORP (JBTM) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:JBTM - US4778391049 - Common Stock

154.39 USD
+2.58 (+1.7%)
Last: 12/19/2025, 8:04:00 PM
154.39 USD
0 (0%)
After Hours: 12/19/2025, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, JBTM scores 3 out of 10 in our fundamental rating. JBTM was compared to 132 industry peers in the Machinery industry. Both the profitability and financial health of JBTM have multiple concerns. While showing a medium growth rate, JBTM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year JBTM was profitable.
In the past year JBTM had a positive cash flow from operations.
JBTM had positive earnings in each of the past 5 years.
Each year in the past 5 years JBTM had a positive operating cash flow.
JBTM Yearly Net Income VS EBIT VS OCF VS FCFJBTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

The Return On Assets of JBTM (-1.35%) is worse than 71.97% of its industry peers.
Looking at the Return On Equity, with a value of -2.50%, JBTM is doing worse than 71.21% of the companies in the same industry.
The Return On Invested Capital of JBTM (1.95%) is worse than 68.94% of its industry peers.
The Average Return On Invested Capital over the past 3 years for JBTM is below the industry average of 10.27%.
Industry RankSector Rank
ROA -1.35%
ROE -2.5%
ROIC 1.95%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
JBTM Yearly ROA, ROE, ROICJBTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

In the last couple of years the Profit Margin of JBTM has declined.
Looking at the Operating Margin, with a value of 4.81%, JBTM is doing worse than 62.12% of the companies in the same industry.
In the last couple of years the Operating Margin of JBTM has declined.
Looking at the Gross Margin, with a value of 35.80%, JBTM is in the better half of the industry, outperforming 65.91% of the companies in the same industry.
In the last couple of years the Gross Margin of JBTM has grown nicely.
Industry RankSector Rank
OM 4.81%
PM (TTM) N/A
GM 35.8%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
JBTM Yearly Profit, Operating, Gross MarginsJBTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

JBTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
JBTM has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, JBTM has more shares outstanding
Compared to 1 year ago, JBTM has a worse debt to assets ratio.
JBTM Yearly Shares OutstandingJBTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
JBTM Yearly Total Debt VS Total AssetsJBTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

JBTM has an Altman-Z score of 1.96. This is not the best score and indicates that JBTM is in the grey zone with still only limited risk for bankruptcy at the moment.
JBTM has a worse Altman-Z score (1.96) than 63.64% of its industry peers.
The Debt to FCF ratio of JBTM is 6.97, which is on the high side as it means it would take JBTM, 6.97 years of fcf income to pay off all of its debts.
JBTM has a Debt to FCF ratio of 6.97. This is comparable to the rest of the industry: JBTM outperforms 46.97% of its industry peers.
JBTM has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
JBTM's Debt to Equity ratio of 0.43 is in line compared to the rest of the industry. JBTM outperforms 53.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.97
Altman-Z 1.96
ROIC/WACC0.21
WACC9.18%
JBTM Yearly LT Debt VS Equity VS FCFJBTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

JBTM has a Current Ratio of 0.93. This is a bad value and indicates that JBTM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.93, JBTM is doing worse than 88.64% of the companies in the same industry.
A Quick Ratio of 0.53 indicates that JBTM may have some problems paying its short term obligations.
The Quick ratio of JBTM (0.53) is worse than 89.39% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.53
JBTM Yearly Current Assets VS Current LiabilitesJBTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

JBTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.08%, which is quite impressive.
Measured over the past 5 years, JBTM shows a small growth in Earnings Per Share. The EPS has been growing by 0.52% on average per year.
Looking at the last year, JBTM shows a very strong growth in Revenue. The Revenue has grown by 92.43%.
Measured over the past years, JBTM shows a decrease in Revenue. The Revenue has been decreasing by -2.48% on average per year.
EPS 1Y (TTM)27.08%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%29.33%
Revenue 1Y (TTM)92.43%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%120.65%

3.2 Future

Based on estimates for the next years, JBTM will show a very strong growth in Earnings Per Share. The EPS will grow by 23.91% on average per year.
JBTM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.83% yearly.
EPS Next Y25.32%
EPS Next 2Y24.33%
EPS Next 3Y23.91%
EPS Next 5YN/A
Revenue Next Year117.04%
Revenue Next 2Y50.56%
Revenue Next 3Y33.89%
Revenue Next 5Y4.83%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
JBTM Yearly Revenue VS EstimatesJBTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
JBTM Yearly EPS VS EstimatesJBTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

JBTM is valuated quite expensively with a Price/Earnings ratio of 25.31.
Compared to the rest of the industry, the Price/Earnings ratio of JBTM is on the same level as its industry peers.
JBTM's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.39.
The Price/Forward Earnings ratio is 19.59, which indicates a rather expensive current valuation of JBTM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of JBTM is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.84, JBTM is valued at the same level.
Industry RankSector Rank
PE 25.31
Fwd PE 19.59
JBTM Price Earnings VS Forward Price EarningsJBTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JBTM indicates a slightly more expensive valuation: JBTM is more expensive than 68.18% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as JBTM.
Industry RankSector Rank
P/FCF 29.34
EV/EBITDA 24.87
JBTM Per share dataJBTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
JBTM's earnings are expected to grow with 23.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)1
PEG (5Y)48.88
EPS Next 2Y24.33%
EPS Next 3Y23.91%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.26%, JBTM is not a good candidate for dividend investing.
JBTM's Dividend Yield is comparable with the industry average which is at 1.04.
Compared to an average S&P500 Dividend Yield of 1.87, JBTM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.26%

5.2 History

The dividend of JBTM has a limited annual growth rate of 0.48%.
JBTM has been paying a dividend for over 5 years, so it has already some track record.
JBTM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.48%
Div Incr Years0
Div Non Decr Years4
JBTM Yearly Dividends per shareJBTM Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

JBTM has negative earnings and hence a negative payout ratio. The dividend may be in danger.
JBTM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-17.36%
EPS Next 2Y24.33%
EPS Next 3Y23.91%
JBTM Yearly Income VS Free CF VS DividendJBTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

JBT MAREL CORP

NYSE:JBTM (12/19/2025, 8:04:00 PM)

After market: 154.39 0 (0%)

154.39

+2.58 (+1.7%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)05-04 2026-05-04
Inst Owners99.26%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner Change-7.52%
Market Cap8.02B
Revenue(TTM)3.26B
Net Income(TTM)-110.60M
Analysts80
Price Target159.94 (3.59%)
Short Float %5.95%
Short Ratio5.57
Dividend
Industry RankSector Rank
Dividend Yield 0.26%
Yearly Dividend0.41
Dividend Growth(5Y)0.48%
DP-17.36%
Div Incr Years0
Div Non Decr Years4
Ex-Date12-15 2025-12-15 (0.1)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.24%
Min EPS beat(2)14.08%
Max EPS beat(2)26.4%
EPS beat(4)3
Avg EPS beat(4)11.49%
Min EPS beat(4)-8.58%
Max EPS beat(4)26.4%
EPS beat(8)5
Avg EPS beat(8)4.11%
EPS beat(12)9
Avg EPS beat(12)6.09%
EPS beat(16)11
Avg EPS beat(16)6.44%
Revenue beat(2)2
Avg Revenue beat(2)3.62%
Min Revenue beat(2)2.12%
Max Revenue beat(2)5.11%
Revenue beat(4)3
Avg Revenue beat(4)0.28%
Min Revenue beat(4)-6.26%
Max Revenue beat(4)5.11%
Revenue beat(8)4
Avg Revenue beat(8)-1.54%
Revenue beat(12)4
Avg Revenue beat(12)-4.62%
Revenue beat(16)5
Avg Revenue beat(16)-3.94%
PT rev (1m)8.29%
PT rev (3m)9.04%
EPS NQ rev (1m)0.01%
EPS NQ rev (3m)0.19%
EPS NY rev (1m)6.46%
EPS NY rev (3m)6.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.9%
Revenue NY rev (1m)1.75%
Revenue NY rev (3m)1.77%
Valuation
Industry RankSector Rank
PE 25.31
Fwd PE 19.59
P/S 2.46
P/FCF 29.34
P/OCF 22.72
P/B 1.81
P/tB N/A
EV/EBITDA 24.87
EPS(TTM)6.1
EY3.95%
EPS(NY)7.88
Fwd EY5.11%
FCF(TTM)5.26
FCFY3.41%
OCF(TTM)6.8
OCFY4.4%
SpS62.69
BVpS85.06
TBVpS-22.35
PEG (NY)1
PEG (5Y)48.88
Graham Number108.05
Profitability
Industry RankSector Rank
ROA -1.35%
ROE -2.5%
ROCE 2.39%
ROIC 1.95%
ROICexc 1.98%
ROICexgc 10.75%
OM 4.81%
PM (TTM) N/A
GM 35.8%
FCFM 8.4%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
ROICexc(3y)7.1%
ROICexc(5y)8.09%
ROICexgc(3y)24.27%
ROICexgc(5y)25.88%
ROCE(3y)6.33%
ROCE(5y)8.04%
ROICexgc growth 3Y-1.29%
ROICexgc growth 5Y-6.67%
ROICexc growth 3Y-5.85%
ROICexc growth 5Y-12.74%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.97
Debt/EBITDA 5.04
Cap/Depr 36%
Cap/Sales 2.45%
Interest Coverage 250
Cash Conversion 93.41%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.53
Altman-Z 1.96
F-Score3
WACC9.18%
ROIC/WACC0.21
Cap/Depr(3y)71.26%
Cap/Depr(5y)66.65%
Cap/Sales(3y)3.61%
Cap/Sales(5y)3.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.08%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%29.33%
EPS Next Y25.32%
EPS Next 2Y24.33%
EPS Next 3Y23.91%
EPS Next 5YN/A
Revenue 1Y (TTM)92.43%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%120.65%
Revenue Next Year117.04%
Revenue Next 2Y50.56%
Revenue Next 3Y33.89%
Revenue Next 5Y4.83%
EBIT growth 1Y-4.04%
EBIT growth 3Y-3.08%
EBIT growth 5Y-9.84%
EBIT Next Year200.73%
EBIT Next 3Y57.39%
EBIT Next 5YN/A
FCF growth 1Y328.68%
FCF growth 3Y4%
FCF growth 5Y22.04%
OCF growth 1Y167.78%
OCF growth 3Y1.15%
OCF growth 5Y16.21%

JBT MAREL CORP / JBTM FAQ

What is the fundamental rating for JBTM stock?

ChartMill assigns a fundamental rating of 3 / 10 to JBTM.


What is the valuation status for JBTM stock?

ChartMill assigns a valuation rating of 3 / 10 to JBT MAREL CORP (JBTM). This can be considered as Overvalued.


Can you provide the profitability details for JBT MAREL CORP?

JBT MAREL CORP (JBTM) has a profitability rating of 3 / 10.


What is the valuation of JBT MAREL CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for JBT MAREL CORP (JBTM) is 25.31 and the Price/Book (PB) ratio is 1.81.


What is the earnings growth outlook for JBT MAREL CORP?

The Earnings per Share (EPS) of JBT MAREL CORP (JBTM) is expected to grow by 25.32% in the next year.